Galecto (GLTO): SEC Form 3 filed by new insider Hewes L. Becker
Stocks in this Quantisnow insightHealth Care
Historical context for GLTO
Across the 6 sessions after earlier GLTO headlines, the stock closed higher 2 times and lower 4 times, with a median move of 8.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | GLTO | SPY |
|---|---|---|---|
| Jan 7, 2026 | Leerink Partners initiated coverage on Galecto with a new price target | -3.8% | -0.3% |
| Jan 6, 2026 | Galecto Announces Key Additions to Leadership Team | +2.7% | +0.6% |
| Dec 17, 2025 | Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | -12.2% | -1.1% |
| Dec 1, 2025 | Guggenheim initiated coverage on Galecto with a new price target | -0.1% | -0.5% |
| Nov 10, 2025 | Galecto Announces Acquisition of Damora Therapeutics | +248.5% | +1.6% |
| Nov 7, 2025 | Galecto Reports Third Quarter 2025 Operating and Financial Results | -14.9% | +0.1% |
Quantisnow market dataNASDAQ
GLTO
Galecto Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for GLTO
Full GLTO profile on Quantisnow Follow GLTO and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time